Chiral carbon nanoparticles (CCNPs) were developed by surface passivation using the chiral ligand (-)-sparteine or (+)-sparteine (denoted (-)-SP/CNP and (+)-SP/CNP, respectively). The chirality of the prepared CCNPs was demonstrated by circular dichroism and polarimetry and employed as an enantioselective separation platform for representative racemic mixtures.
Manipulating the chiroptical properties
at the nanoscale is of
great importance in stereoselective reactions, enantioseparation,
self-assembly, and biological phenomena. In recent years, carbon dots
have garnered great attention because of their favorable properties
such as tunable fluorescence, high biocompatibility, and facile, scalable
synthetic procedures. Herein, we report for the first time the unusual
behavior of cyclic amino acids on the surface of carbon dots prepared
via microwave-based carbonization. Various amino acids were introduced
on the surface of carbon dots via EDC/NHS conjugation at room temperature.
Circular dichroism results revealed that although most of the surface
conjugated amino acids can preserve their chirality on negatively
charged, “bare” carbon dots, the “handedness”
of cyclic α-amino acids can be flipped when covalently attached
on carbon dots. Moreover, these chiroptical carbon dots were found
to interact with the cellular membrane or its mimic in a highly selective
manner due to their acquired asymmetric selectivity. A comprehensive
inhibitor study was conducted to investigate the pathway of cellular
trafficking of these carbon dots. Overall, it was concluded that the
chirality of the amino acid on the surface of carbon dots could regulate
many of the cellular processes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.